Sudarshan Pharma Industries Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,92,000 shares,. Its Average Traded Price (ATP) is ₹39.13, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 4000 @ ₹39.00.
Sudarshan Pharma Industries has an upper circuit limit of ₹41.42 and a lower circuit limit of ₹37.48. The total value traded stands at ₹75.13 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 4000. Sudarshan Pharma Industries also offers a dividend yield of 0%.
Sudarshan Pharma Industries Share Price Chart
Sudarshan Pharma Industries Share Key Metrics
Volume
1.92 L
Market Cap
1003.89 CR
LTQ@LTP
4000@39.00
ATP
39.13
Var Margin
53.5 %
Circuit Range
37.48-41.42
Delivery %
100 %
Value
75.13 L
ASM/GSM
No
Market Lot
4000
Sudarshan Pharma Industries Resistance and Support
Pivot 39.65
Resistance
First Resistance
39.85
Second Resistance
40.2
Third Resistance
40.4
Support
First Support
39.3
Second Support
39.1
Third Support
38.75
Sudarshan Pharma Industries Shareholding Pattern
View More- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Sudarshan Pharma Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-06-18 | Issue Of Warrants |
| 2026-05-21 | Others |
| 2026-05-15 | Others |
| 2026-04-30 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-10-18 | Half Yearly Results |
| 2025-08-14 | Quarterly Results |
| 2025-06-19 | Others |
| 2025-04-24 | Audited Results |
| 2025-01-10 | To consider issue of Warrants |
| 2024-10-31 | Half Yearly Results |
| 2024-09-30 | Stock Split |
| 2024-07-04 | Others |
| Split Ratio | Split Date | |
|---|---|---|
| 10:1 | 2024-11-22 | View More |
Sudarshan Pharma Industries News
Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma Industries' promoter group pledged 2.92% of the company's shares (70.62 lakh shares) to Gangabase Private Limited. This pledge acts as security for a loan taken by Sudarshan Pharma Industries Limited.
Sep 09 2026 19:59:33
Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma Promoter Hemal Mehta released 20 lakh pledged equity shares, which is 0.83% of the company's total share capital. The shares were originally pledged to secure a personal loan for the promoter.
Sep 09 2026 19:57:43
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition
Sudarshan Pharma Industries acquired a 9.50% stake in MedTherapy Biotechnology Inc., a US-based cancer cell and gene therapy company. This acquisition will enable entry into the US market, access new customer bases, and expand product and service offerings.
Sep 05 2026 19:34:25
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma's promoters, Hemal V. Mehta and Sachin V. Mehta, each pledged 6.65 million shares, representing 2.61% of the total share capital, on August 25, 2026. This increases their individual total pledged holdings to 5.21% of total share capital.
Aug 26 2026 19:31:15
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma Industries' promoters, Hemal V Mehta and Sachin V Mehta, each pledged 6.6 million shares. This collectively represents 5.28% of the company's total equity, providing security for a loan taken by Sudarshan Pharma Industries.
Aug 22 2026 10:13:09
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment
Sudarshan Pharma Industries Ltd has allotted 48.11 lakh fully paid-up equity shares with a face value of Re.1 each, converting USD 1.5 million in Foreign Currency Convertible Bonds. The issue price was Rs.30.19 per share, increasing total shares to 25.44 crore.
Aug 19 2026 18:44:38
Sudarshan Pharma Industries Ltd - 543828 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma's promoter group pledged a total of approximately 7.7 million equity shares, representing 3.18% of the company's total paid-up capital. This action was taken to secure loans for the company on August 13, 2026.
Aug 17 2026 08:23:11
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition
Sudarshan Pharma Industries has entered an MOU to acquire a 76% stake in a pharmaceutical manufacturing unit in Vizag. The consideration includes cash and 40 lakh shares of Sudarshan Pharma, with the aim to achieve backward integration and launch end-to-end manufacturing capabilities.
Aug 13 2026 17:34:27
Sudarshan Pharma Industries Management
| Name | Position |
|---|---|
| Nirav Shah | Company Secretary & Compliance Officer |
| Hemal Vasantrai Mehta | Chairman & Managing Director |
Sudarshan Pharma Industries Similar Stocks
Bajaj Healthcare Ltd.
334.10
0.90 (0.27%)
Kopran Ltd.
235.55
-0.10 (0.04%)
Laxmi Dental Ltd.
203.70
1.05 (0.52%)
Bharat Parenterals Ltd.
1530.00
-20.55 (1.33%)
Anuh Pharma Ltd.
95.00
3.61 (3.95%)
Anlon Healthcare Ltd.
19.52
1.96 (11.16%)
Wanbury Ltd.
238.05
-3.90 (1.61%)
Shree Ganesh Remedies Ltd.
660.00
30.55 (4.85%)
Gaudium IVF and Women Health Ltd.
118.50
4.00 (3.49%)
Sudarshan Pharma Industries FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SUDARSHAN
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC